When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - Zogenix acquires Modis Therapeutics for up to $400M
Zogenix Inc.
Zogenix (NASDAQ:ZGNX) has agreed to acquire privately held Oakland, CA-based Modis Therapeutics, a developer of therapies for rare inherited diseases. Lead candidate is MT1621 for the treatment of thymidine kinase 2 deficiency, an inherited mitochondrial DNA depletion disorder that is frequently fatal.
More news on: Zogenix, Inc., Healthcare stocks news, Merger & acquisition news,